Barclays PLC Kiniksa Pharmaceuticals, Ltd. Transaction History

Barclays PLC

  • $377 Billion
  • Q3 2024

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$16.88 - $20.33 $123,359 - $148,571
-7,308 Reduced 17.34%
34,839 $650,000
Q1 2024

May 15, 2024
SELL
$17.63 - $21.74 $2.53 Million - $3.12 Million
-143,609 Reduced 77.31%
42,147 $831,000
Q4 2023

Feb 15, 2024
BUY
$14.37 - $19.07 $147,019 - $195,105
10,231 Added 5.83%
185,756 $3.26 Million
Q3 2023

Nov 07, 2023
BUY
$13.62 - $20.2 $175,248 - $259,913
12,867 Added 7.91%
175,525 $3.05 Million
Q2 2023

Aug 03, 2023
BUY
$10.44 - $16.48 $5,000 - $7,893
479 Added 0.3%
162,658 $2.29 Million
Q1 2023

May 04, 2023
BUY
$10.7 - $15.79 $1.09 Million - $1.61 Million
102,172 Added 170.27%
162,179 $1.75 Million
Q4 2022

Feb 13, 2023
BUY
$11.42 - $17.05 $430,145 - $642,205
37,666 Added 168.6%
60,007 $899,000
Q3 2022

Nov 03, 2022
BUY
$9.76 - $13.41 $58,257 - $80,044
5,969 Added 36.46%
22,341 $287,000
Q2 2022

Aug 12, 2022
SELL
$7.6 - $11.41 $24,996 - $37,527
-3,289 Reduced 16.73%
16,372 $158,000
Q1 2022

May 16, 2022
SELL
$9.3 - $12.37 $333,618 - $443,749
-35,873 Reduced 64.6%
19,661 $195,000
Q4 2021

Feb 14, 2022
SELL
$10.39 - $15.15 $218,460 - $318,543
-21,026 Reduced 27.46%
55,534 $653,000
Q3 2021

Nov 09, 2021
BUY
$11.39 - $16.23 $646,166 - $920,744
56,731 Added 286.1%
76,560 $872,000
Q2 2021

Aug 13, 2021
SELL
$13.22 - $19.09 $3.12 Million - $4.5 Million
-235,707 Reduced 92.24%
19,829 $275,000
Q1 2021

May 13, 2021
SELL
$16.68 - $23.97 $7.1 Million - $10.2 Million
-425,364 Reduced 62.47%
255,536 $4.73 Million
Q4 2020

Feb 11, 2021
BUY
$14.8 - $21.15 $5.81 Million - $8.3 Million
392,512 Added 136.11%
680,900 $12 Million
Q3 2020

Nov 12, 2020
BUY
$15.21 - $25.53 $4.13 Million - $6.94 Million
271,796 Added 1638.11%
288,388 $4.42 Million
Q2 2020

Aug 12, 2020
BUY
$15.08 - $26.0 $156,334 - $269,542
10,367 Added 166.54%
16,592 $423,000
Q1 2020

May 13, 2020
SELL
$11.0 - $19.76 $132,638 - $238,266
-12,058 Reduced 65.95%
6,225 $97,000
Q4 2019

Feb 10, 2020
BUY
$5.24 - $12.96 $35,967 - $88,957
6,864 Added 60.11%
18,283 $202,000
Q3 2019

Nov 14, 2019
BUY
$8.15 - $15.88 $2,151 - $4,192
264 Added 2.37%
11,419 $98,000
Q2 2019

Aug 14, 2019
BUY
$13.2 - $20.39 $89,628 - $138,448
6,790 Added 155.56%
11,155 $151,000
Q1 2019

May 15, 2019
BUY
$15.93 - $26.59 $20,884 - $34,859
1,311 Added 42.93%
4,365 $80,000
Q4 2018

Feb 14, 2019
BUY
$16.25 - $28.09 $10,140 - $17,528
624 Added 25.68%
3,054 $86,000
Q3 2018

Nov 14, 2018
BUY
$13.23 - $30.93 $32,148 - $75,159
2,430 New
2,430 $62,000

Others Institutions Holding KNSA

# of Institutions
8
Shares Held
1.95M
Call Options Held
0
Put Options Held
0
View Full List

About Kiniksa Pharmaceuticals, Ltd.

KNSA Quotes by TradingView
  • Ticker KNSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,470,400
  • Market Cap $734M
  • Description
  • Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...
More about KNSA
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email